Zdrowie i gospodarka · 07/11/2018

FDA Announces Final Guidance for Developing Fixed-Combination Drug Products for Hypertension Treatment

The US Food and Drug Administration (FDA) has released a final guidance document to help pharmaceutical companies develop fixed-combination drug products for treating high blood pressure, building on comments received since its initial release in 2018.